SBIR/STTR Research Award
IGF OT IGF A SHARED DECISION MAKING TOOL TO PREVENT SUBSTANCE ABUSE PERIOD OF PERFORMANCE SEPTEMBER SEPTEMBER BASE AWARD N DA
Award amount
$999,389Program and phase
SBIR · Phase IIAward year
2016Award details
- Awarding agency
- Department of Health and Human Services
- Branch
- National Institutes of Health
- Recipient company
- RINGFUL LLC
- Proposal award date
- Not reported
- Contract end date
- Not reported
- UEI
- Not reported
- Solicitation number
- Not reported
- Topic code
- NIDA
Research abstract
The goal of this SBIR phase II project is to evaluate the efficacy of a mobile technology based system to increase the proportion of primary care patients who are successfully linked to and receive indicated follow up specialty substance use disorders SUD care The system should demonstrate that it can enable primary care practices to better implement substance abuse prevention guidelines such as Screening Brief Intervention and Referral to Treatment SBIRT The system engages both patients and clinicians for Shared Decision Making SDM in the primary care setting and follows through the decisions after the patient goes home The system will be guided by the latest research on cognitive design in healthcare IT systems and be evaluated in a real world primary care clinic for acceptance and engagement
Technology keywords
Not reported
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- Wearable Wireless Respiratory Monitoring System that Detects and Predicts Opioid Induced Respiratory Depression
- Building and testing the Life Enhancement and Advocacy Programming digital training tool (LEAPLink) to better serve people with lived experience of homelessness and substance use disorder
- A digital intervention to decrease self-stigma among pregnant and postpartum women with opioid use disorder
- Development of medication for the treatment of respiratory depression due to opioid (prescribed or illicit) overdose/multidrug (polysubstance) overdose in a hospital or community setting.
- Creation and Validation of the Dose-Opioid-Source Evaluation tool (DOSE) - a Robust Opioid Use Clinical Outcome Assessment for Qualification as an FDA Medical Device Development Tool (MDDT)